Futura Medical (LON:FUM) Issues Earnings Results

Futura Medical (LON:FUM) announced its quarterly earnings results on Tuesday. The company reported GBX (0.20) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Futura Medical had a negative return on equity of 152.42% and a negative net margin of 158.21%.

Futura Medical Stock Performance

Shares of LON:FUM remained flat at GBX 0.28 during trading on Friday. The stock had a trading volume of 8,514,553 shares, compared to its average volume of 9,210,257. Futura Medical has a one year low of GBX 0.20 and a one year high of GBX 10.45. The stock has a fifty day moving average price of GBX 0.41 and a two-hundred day moving average price of GBX 0.77. The stock has a market capitalization of £1.62 million, a price-to-earnings ratio of -0.10 and a beta of 0.02.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.